pillbase.ru

Zinmyleo

Active substance: trilaciclib

trilaciclib dihydrochloride

Centralised EU authorisationActive

Marketing holder: Pharmacosmos A/S

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • COSELA
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TRILACICLIB DIHYDROCHLORIDE 300 mg/20mL
    73594-0101
    Pharmacosmos Therapeutics Inc.
  • COSELA
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TRILACICLIB DIHYDROCHLORIDE 300 mg/20mL
    73462-101
    G1 Therapeutics, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2ed9-719c-8370-fc713b44bcd5,01a12090-f257-7524-9f05-43b34a28bc0b;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006709
Registration status
Active
ATC code
V03AF12
Sources
  • product · EMA · EMEA/H/C/006709 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006709 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006709 · Verified 2026-10-09